Biomarker ID | 925 |
PMID | 22589488 |
Year | 2012 |
Biomarker | Methylation Status Of HIF3A; HAAO; RARb; GSTP1 |
Biomarker Basis | Methylation Based |
Biomolecule | Methylation |
Source | Tissue |
Subjects | Humans |
Regulation | Methylated with Systemic Recurrence |
Odds Ratio/Hazard Ratio/Relative Risk | NA |
Effect on Pathways | NA |
Experiment | Tumor Vs Normal Tissues |
Type of Biomarker | Diagnostic |
Cohort | 4 different sub groups of patients with prostate cancer: (i) tumor versus matched normal tissues ((ii) recurrence versus nonrecurrence (iii) clinical versus biochemical recurrence and (iv) systemic recurrence versus local recurrence. 20 patients from each group were taken |
Senstivity | NA |
Specificity | NA |
AUC | NA |
Accuracy | NA |
Level Of Significance | p<0.0182 |
Method Used | Methylation27 microarrays |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Not validated on independent patient dataset |
Technical Name | HIF3A, HAAO, RARb, GSTP1 |